Alta Advisers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $470K | Hold |
10,150
| – | – | 0.17% | 110 |
|
|
2025
Q1 | $619K | Buy |
10,150
+3,400
| +50% | +$207K | 0.26% | 80 |
|
|
2024
Q4 | $382K | Buy |
6,750
+1,250
| +23% | +$70.7K | 0.24% | 84 |
|
|
2024
Q3 | $285K | Hold |
5,500
| – | – | 0.13% | 100 |
|
|
2024
Q2 | $228K | Hold |
5,500
| – | – | 0.11% | 110 |
|
|
2024
Q1 | $298K | Hold |
5,500
| – | – | 0.15% | 83 |
|
|
2023
Q4 | $282K | Hold |
5,500
| – | – | 0.15% | 82 |
|
|
2023
Q3 | $319K | Hold |
5,500
| – | – | 0.19% | 64 |
|
|
2023
Q2 | $352K | Hold |
5,500
| – | – | 0.2% | 59 |
|
|
2023
Q1 | $381K | Hold |
5,500
| – | – | 0.23% | 52 |
|
|
2022
Q4 | $396K | Hold |
5,500
| – | – | 0.24% | 50 |
|
|
2022
Q3 | $391K | Buy |
+5,500
| New | +$391K | 0.25% | 43 |
|